Keywords: USA GPhA, Supreme Court, Caraco, Novo Nordisk, America Invents Act, Patent process, HR 1249

USA’s GPhA calls on FDA to support Supreme Court review of “case that threatens generic competition”

Article | 15 April 2011

The USA’s Generic Pharmaceutical Association (GPhA) has written a letter to Food and Drug Administration Commissioner Margaret Hamburg ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in